Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ELVIRA O GOSMANOVA

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1437379989
CMS profile
111021
Location
ALBANY, NY

General Payments · PY2018–2024

$33,130.14

  • Reported across 43 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$5,102.28

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Ascendis Pharma Inc $3,562.29 3
Alexion Pharmaceuticals, Inc. $1,509.89 9
Medtronic, Inc. $30.10 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $6,241.53 7
PY2019 $4,348.45 10
PY2021 $6,706.65 3
PY2022 $2,640.00 1
PY2023 $8,091.23 9
PY2024 $5,102.28 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $649.07 08/19/2024 Travel and Lodging Undisputed 01/23/2026 1094001943 CMS
Alexion Pharmaceuticals, Inc. $135.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 1093888041 CMS
Alexion Pharmaceuticals, Inc. $135.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 1093916633 CMS
Alexion Pharmaceuticals, Inc. $197.22 09/19/2024 Travel and Lodging Undisputed 01/23/2026 1093922044 CMS
Alexion Pharmaceuticals, Inc. $50.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 1093924519 CMS
Alexion Pharmaceuticals, Inc. $203.60 09/19/2024 Travel and Lodging Undisputed 01/23/2026 1093961934 CMS
Alexion Pharmaceuticals, Inc. $40.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 1093971912 CMS
Alexion Pharmaceuticals, Inc. $40.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 1094034911 CMS
Alexion Pharmaceuticals, Inc. $60.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 1094038234 CMS
Ascendis Pharma Inc $153.29 09/28/2024 Food and Beverage Undisputed 01/23/2026 1133847920 CMS
Ascendis Pharma Inc $2,435.00 10/21/2024 Consulting Fee Undisputed 01/23/2026 1133848842 CMS
Ascendis Pharma Inc $974.00 12/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133851058 CMS
Medtronic, Inc. $30.10 11/30/2024 Food and Beverage Undisputed 01/23/2026 1119317946 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.